Group One Trading’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.79M | Sell |
23,200
-14,000
| -38% | -$4.6M | 0.01% | 1087 |
|
|
2025
Q4 | $13M | Sell |
37,200
-51,600
| -58% | -$17.4M | 0.02% | 795 |
|
|
2025
Q3 | $28.7M | Buy |
88,800
+47,000
| +112% | +$14.6M | 0.05% | 349 |
|
|
2025
Q2 | $16.3M | Sell |
41,800
-1,100
| -3% | -$442K | 0.04% | 536 |
|
|
2025
Q1 | $18.7M | Sell |
42,900
-17,200
| -29% | -$6.9M | 0.05% | 346 |
|
|
2024
Q4 | $22.2M | Buy |
60,100
+24,600
| +69% | +$10.3M | 0.05% | 347 |
|
|
2024
Q3 | $18.5M | Buy |
35,500
+19,600
| +123% | +$10.5M | 0.05% | 310 |
|
|
2024
Q2 | $8.62M | Buy |
15,900
+15,300
| +2,550% | +$8.09M | 0.03% | 521 |
|
|
2024
Q1 | $311K | Sell |
600
-6,700
| -92% | -$3.33M | ﹤0.01% | 3184 |
|
|
2023
Q4 | $3.44M | Sell |
7,300
-2,000
| -22% | -$925K | 0.01% | 1418 |
|
|
2023
Q3 | $4.05M | Buy |
9,300
+300
| +3% | +$136K | 0.01% | 1077 |
|
|
2023
Q2 | $4M | Buy |
9,000
+6,500
| +260% | +$3M | 0.01% | 1142 |
|
|
2023
Q1 | $1.15M | Sell |
2,500
-4,900
| -66% | -$2.33M | ﹤0.01% | 2018 |
|
|
2022
Q4 | $3.8M | Sell |
7,400
-1,100
| -13% | -$559K | 0.01% | 1335 |
|
|
2022
Q3 | $3.86M | Buy |
8,500
+1,600
| +23% | +$766K | 0.01% | 1370 |
|
|
2022
Q2 | $3.33M | Buy |
6,900
+800
| +13% | +$396K | 0.01% | 1605 |
|
|
2022
Q1 | $3M | Sell |
6,100
-12,700
| -68% | -$5.81M | ﹤0.01% | 1990 |
|
|
2021
Q4 | $8.71M | Sell |
18,800
-1,400
| -7% | -$589K | 0.01% | 1212 |
|
|
2021
Q3 | $7.53M | Sell |
20,200
-20,800
| -51% | -$7.9M | 0.01% | 1319 |
|
|
2021
Q2 | $15.7M | Sell |
41,000
-300
| -0.7% | -$115K | 0.02% | 784 |
|
|
2021
Q1 | $14.8M | Buy |
41,300
+6,500
| +19% | +$2.09M | 0.02% | 693 |
|
|
2020
Q4 | $11.2M | Buy |
34,800
+4,200
| +14% | +$1.29M | 0.02% | 746 |
|
|
2020
Q3 | $8.22M | Buy |
30,600
+4,900
| +19% | +$1.32M | 0.03% | 623 |
|
|
2020
Q2 | $6.76M | Sell |
25,700
-9,400
| -27% | -$2.51M | 0.03% | 616 |
|
|
2020
Q1 | $7.97M | Buy |
35,100
+16,400
| +88% | +$4.47M | 0.06% | 332 |
|
|
2019
Q4 | $5.65M | Sell |
18,700
-5,300
| -22% | -$1.46M | 0.04% | 611 |
|
|
2019
Q3 | $5.76M | Buy |
24,000
+10,300
| +75% | +$2.82M | 0.05% | 502 |
|
|
2019
Q2 | $3.87M | Buy |
+13,700
| New | +$3.74M | 0.04% | 677 |
|
|
2019
Q1 | – | Sell |
-500
| Closed | -$131K | – | 4940 |
|
|
2018
Q4 | $131K | Buy |
+500
| New | +$137K | ﹤0.01% | 2996 |
|
|
2018
Q3 | – | Sell |
-5,000
| Closed | -$1.19M | – | 5287 |
|
|
2018
Q2 | $1.19M | Buy |
5,000
+3,900
| +355% | +$903K | 0.01% | 1551 |
|
|
2018
Q1 | $242K | Sell |
1,100
-5,700
| -84% | -$1.34M | ﹤0.01% | 2631 |
|
|
2017
Q4 | $1.53M | Sell |
6,800
-1,000
| -13% | -$213K | 0.01% | 1370 |
|
|
2017
Q3 | $1.48M | Buy |
7,800
+800
| +11% | +$152K | 0.01% | 1270 |
|
|
2017
Q2 | $1.32M | Sell |
7,000
-9,100
| -57% | -$1.64M | 0.01% | 1254 |
|
|
2017
Q1 | $2.66M | Buy |
16,100
+5,300
| +49% | +$843K | 0.03% | 686 |
|
|
2016
Q4 | $1.55M | Buy |
+10,800
| New | +$1.45M | 0.02% | 1053 |
|
Other funds holding ELV
VCM
VPM
Group One Trading's ELV Position: Q1 2026 in Review
Group One Trading reduced its Elevance Health (ELV) stake by 60% in Q1 2026, selling an estimated $1.32M and leaving 2,707 shares worth $792K. The position accounts for ﹤0.01% of the portfolio, ranked #2924.
Group One Trading first reported a position in ELV in Q2 2017 and has held it in 15 quarters since. The position peaked at $20.3M in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Group One Trading held 2,707 shares of Elevance Health worth $792K as of Q1 2026.
- Group One Trading sold 4,031 Elevance Health shares in Q1 2026, an estimated $1.32M.
- Elevance Health made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2924 holding.
- Group One Trading first reported a position in Elevance Health in Q2 2017 and has held it in 15 quarters since.
- Group One Trading's Elevance Health position peaked at $20.3M in Q1 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.